Evidence map›Paper›PMID 42818372›Full record

ArticlebioRxiv : the preprint server for biology2026

CypA is a molecular barrier to HIV emergence from Eastern chimpanzees.

Michael J Young, Fabricio Cotera, Clare C C Gill, Jacob A Lewis, Frank G Whitby, Alaa Abdel-Latif, Joana L Rocha, Michael Singer, Mike A Nalls, Faraz Faghri and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michael J YoungDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.ORCID 0000-0002-9167-2413
Fabricio CoteraDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.
Clare C C GillDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.ORCID 0009-0005-6689-702X
Jacob A LewisDepartment of Biochemistry, University of Utah; Salt Lake City, UT, 84112, USA.
Frank G WhitbyDepartment of Biochemistry, University of Utah; Salt Lake City, UT, 84112, USA.ORCID 0000-0003-3511-2216
Alaa Abdel-LatifUniversity of California San Francisco Center for AIDS Research (CFAR); San Francisco, CA, 94143, USA.
Joana L RochaDepartment of Integrative Biology, University of California Berkeley; Berkeley, CA, 94720, USA.
Michael SingerDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.
Mike A NallsCenter for Alzheimer's and Related Dementias, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institutes of Health; Bethesda, MD, 20892, USA.
Faraz FaghriCenter for Alzheimer's and Related Dementias, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institutes of Health; Bethesda, MD, 20892, USA.
Peter H SudmantDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.ORCID 0000-0002-9573-8248
Owen PornillosDepartment of Biochemistry, University of Utah; Salt Lake City, UT, 84112, USA.ORCID 0000-0001-9056-5002
Molly OhainleDepartment of Molecular and Cell Biology, University of California Berkeley; Berkeley, CA, 94720, USA.ORCID 0000-0001-5138-5367

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral DynamicsU54AI170856 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI WESLEY I. SUNDQUIST · 2022 to 2026
$34.4M
Lentiviral Restriction: capsid and beyondR01AI147877 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI Molly OhAinle · 2019 to 2026
$4.2M
The evolution and diversity of mutation, molecular fidelity, and genome structureR35GM142916 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Peter Heshedahl Sudmant · 2021 to 2026
$2.5M
A compendium of complete primate reference genomes to facilitate conservation, genomics, and ecologyR01HG013017 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Erik Garrison, Matthew William Mitchell · 2023 to 2026
$1.9M
NCI NIH HHS P30 CA015704NHGRI NIH HHS R01 HG013017NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI147877NIAID NIH HHS U54 AI170856NIGMS NIH HHS R35 GM142916
6 · The paper itself

Abstract

Of the two lineages of lentivirus that endemically infect chimpanzees, only one has served as a source of infections in humans. Using HIV-CRISPR screening, we identify factors that limit the replication of lentivirus from Eastern chimpanzees. We find that CypA restricts nonzoonotic Eastern chimpanzee lentivirus due to a unique feature encoded in capsid. The ability of CypA to restrict lentivirus replication is surprising given that CypA is a host factor exploited by HIV to promote its replication. The selective ability of CypA to restrict this virus provides a molecular explanation as to why lentivirus from Eastern Chimpanzees has never been observed to infect humans. Our work has important implications for understanding the origins of HIV-1 and the potential for novel zoonosis of primate lentiviruses.

Identifiers

PMID42818372
PMCPMC13622688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.